Myostatin and follistatin as monitoring and prognostic biomarkers in dysferlinopathy
© 2023 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
| Autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2023 |
| País: | España |
| Institución: | Consejo Superior de Investigaciones Científicas (CSIC) |
| Repositorio: | DIGITAL.CSIC. Repositorio Institucional del CSIC |
| OAI Identifier: | oai:digital.csic.es:10261/351975 |
| Acceso en línea: | http://hdl.handle.net/10261/351975 |
| Access Level: | acceso abierto |
| Palabra clave: | Myostatin Follistatin Muscular dystrophy Dysferlinopathy Limb girdle muscular dystrophy R2 Miyoshi myopathy |
| Sumario: | © 2023 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/) |
|---|